Cullen Frost Bankers »

Janux Therapeutics shares owned by Cullen Frost Bankers

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Cullen Frost Bankers from 13F filings

Historical chart of Cullen Frost Bankers investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Cullen Frost Bankers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Cullen Frost Bankers

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.9k 173 45.43
2024-06-30 $7.1k 169 41.89

More positions owned by Cullen Frost Bankers

Apple Domestic Common Stock (AAPL)
Microsoft Corp Domestic Common Stock (MSFT)
Vanguard Index Fds Growth Etf Domestic Large Cap Fund-etf (VUG)
Nvidia Corporation Domestic Common Stock (NVDA)
Amazon Domestic Common Stock (AMZN)
Ishares Tr Rus 1000 Grw Etf Domestic Large Cap Fund-etf (IWF)
Ishares Inc Msci Emrg Chn Intl Emerging Mkts Fund-etf (EMXC)
Ishares Tr Msci Eafe Etf Intl Developed Mkts Fund-etf (EFA)
Schwab Strategic Tr Us Dividend Eq Domestic Large Cap Fund-etf (SCHD)
Spdr S&p 500 Etf Tr Tr Unit Domestic Large Cap Fund-etf (SPY)
Meta Platforms Inc Cl A Domestic Common Stock (META)
Alphabet Inc Cap Stk Cl A Domestic Common Stock (GOOGL)
Vanguard Index Fds Mid Cap Etf Domestic Mid Cap Fund-etf (VO)
Ishares Tr 20 Yr Tr Bd Etf Domestic Taxable Invt Grade-etf (TLT)
Vanguard Index Fds Small Cp Etf Domestic Small Cap Fund-etf (VB)

View all positions for Cullen Frost Bankers

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Paradigm Biocapital Advisors
BlackRock
Henderson Group
Woodline Partners
Vanguard Group
EcoR1 Capital
State Street Corporation
OrbiMed Advisors
Citadel Advisors
Cormorant Asset Management
Logos Global Management
Lord, Abbett & Co
Geode Capital Management

View all funds holding Janux Therapeutics